Detalhe da pesquisa
1.
Liver-selective glucocorticoid receptor antagonism decreases glucose production and increases glucose disposal, ameliorating insulin resistance.
Metabolism
; 56(3): 380-7, 2007 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-17292727
2.
Selective antagonism of the hepatic glucocorticoid receptor reduces hepatic glucose production.
Metabolism
; 55(9): 1255-62, 2006 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-16919547
3.
Spectroscopic studies of aqueous gallium(III) and aluminum(III) citrate complexes.
J Inorg Biochem
; 99(3): 716-26, 2005 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15708792
4.
Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetes.
J Med Chem
; 47(17): 4213-30, 2004 Aug 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-15293993
5.
Interactions between GaO4Al12(OH)24(H2O)12(7+) and cellulosic materials.
J Colloid Interface Sci
; 374(1): 250-7, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22386204
6.
A multitechnique study of the interactions between H+, Na+, Ca2+ and Cu2+, and two types of softwood Kraft fibre materials.
J Colloid Interface Sci
; 328(2): 248-56, 2008 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18849049
7.
Synthesis and activity of novel bile-acid conjugated glucocorticoid receptor antagonists.
Bioorg Med Chem Lett
; 16(23): 6086-90, 2006 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16987661
8.
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetes.
J Pharmacol Exp Ther
; 314(1): 191-200, 2005 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15784656
9.
The three-dimensional structures of antagonistic and agonistic forms of the glucocorticoid receptor ligand-binding domain: RU-486 induces a transconformation that leads to active antagonism.
J Biol Chem
; 278(25): 22748-54, 2003 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-12686538